NVO Stock — Novo Nordisk A/S

Novo Nordisk A/S (NVO)

NVO is a Stock. As of September 3, 2026, its distribution rate is 3.60%, its trailing-12-month yield is 3.90%. Dividend Vision Distribution Safety Score™ is 66/100 (Generally safe). Its deepest 1-year drawdown was 43.7%.

At the current 3.60% distribution rate, a $10,000 investment would generate approximately $360 per year, or $30.00 per month on an equivalent basis. Actual semi-annual payments vary.

Novo Nordisk is a Danish pharmaceutical company that researches, develops, manufactures, and distributes medicines across two main business segments: Obesity and Diabetes Care, which includes products for diabetes, obesity, cardiovascular conditions, and newer therapies like Wegovy; and Rare Disease, which addresses rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company pays distributions on a semi-annual basis at a modest current rate. Novo Nordisk appeals to dividend investors seeking exposure to the healthcare and pharmaceutical sectors with regular income.

NVO performance

Data as of September 3, 2026.

Its deepest 1-year drawdown was 43.7%.

NVO key facts

Data as of September 3, 2026.

Distribution Safety Score™

66 · Generally safe

Safety-Adjusted Yield

2.38%

Asset type

Stock

Asset class

Equity

Inception date

04/30/1981

Distribution rate

3.60%

Distribution frequency

Semi-Annual

Trailing yield

3.90%

5-year average yield

1.9

Last close

$47.51

Market cap

$158,975,972,471

Average volume

8764621.0

Last dividend

$0.579

Last ex-dividend date

08/17/2026

Last payment date

08/25/2026

Beta

0.349

Payout ratio

0.1266

P/E ratio

11.26

Forward P/E

13.7552

EPS

$4.22

How Dividend Vision calculates yield and returns

Distribution rate (3.60%) is the latest regular payout annualized by the fund's stated frequency, divided by the last close. Issuers often publish this as “Distribution Rate” on the fact sheet. Trailing-12-month yield (3.90%) is the sum of distributions paid in the last 12 months, split-adjusted, divided by the last close. It lags a recent raise or cut. We show a 30-day SEC yield when the fund publishes one. Schwab and other issuers may report a TTM distribution yield or SEC yield on a different date — all can be valid; they are not interchangeable. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss. Figures below use Dividend Vision data as of September 3, 2026.

Distribution rate methodology · Distribution Safety Score methodology · SEC yield

Sources and review

Data as of September 3, 2026.

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

NVO risks and drawbacks

NVO's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are semi-annual, so cash flow is lumpy versus a monthly fund. The deepest 1-year drawdown on record here is 43.7%.

Who may consider NVO — and who may not

NVO may suit someone looking for moderate current income with a quality tilt. It is a weaker fit for investors who need monthly cash flow (NVO pays semi-annual); investors hunting double-digit covered-call yields. This is educational context, not a recommendation to buy or sell.

Frequently asked questions